Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1850769Generated: November 2, 2026

tert-Butyl isocyanate → N-(tert-butyl)-4-((1R,2S)-2-(2-(4-(1H-tetrazol-1-yl)phenoxy)ethyl)cyclopropyl)piperidine-1-carboxamide

https://huagongshe.com/reaction/1850769

Reaction equation

Participants

RoleNameHCIDCharge
Reactanttert-Butyl isocyanateHCID 62412—
ReactantDiisopropylethylamineHCID 81531—
Reactant4-((1R,2S)-2-(2-(4-(1H-tetrazol-1-yl)phenoxy)ethyl)cyclopropyl)piperidineHCID 86711185—
SolventDimethylformamideHCID 6228—
ProductN-(tert-butyl)-4-((1R,2S)-2-(2-(4-(1H-tetrazol-1-yl)phenoxy)ethyl)cyclopropyl)piperidine-1-carboxamideHCID 70856344—

Reaction Steps

To a solution of 4-((1R,2S)-2-(2-(4-(1H-tetrazol-1-yl)phenoxy)ethyl)cyclopropyl)piperidine (20 mg, 0.064 mmol) in DMF (0.7 ml) under nitrogen at RT was added DIPEA (0.022 ml, 0.128 mmol) followed by t-butyl isocyanate (drop). At 20 minutes, LC/MS showed no SM left. Quenched with formic acid (4.90 μl, 0. The fractions containing product were collected and dried via GenoVac to afford the title compound. GPR119 Human EC50: 14.7 nM

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08957062B2
Source datasetuspto-grants-2015_02
ORD IDord-6774ea93b18a48b1ae6a87a3235951ee
Source noteuspto-grants-2015_02